Qcm Cayman, Ltd. Intercept Pharmaceuticals, Inc. Transaction History

Qcm Cayman, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$91.83 - $120.68 $200,281 - $263,203	-2,181 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $187,107 - $275,809	2,181 New	2,181 $220,000
Q3 2017 Nov 14, 2017	SELL	$57.01 - $118.75 $111,454 - $232,156	-1,955 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	1,955	1,955 $237,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Qcm Cayman, Ltd., based on Form 13F filings with the SEC.

Stay updated on Qcm Cayman, Ltd. with notifications on news.